The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical relevance of mutations in patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms with normal karyotype.
 
Guillermo Montalban-Bravo
No Relationships to Disclose
 
Ana Alfonso Pierola
No Relationships to Disclose
 
Koichi Takahashi
No Relationships to Disclose
 
Marina Konopleva
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Abbvie; Calithera Biosciences; Genentech
Consulting or Advisory Role - AbbVie
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Stemline Therapeutics (Inst)
 
Elias Jabbour
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Gautam Borthakur
No Relationships to Disclose
 
Naval Guastad Daver
No Relationships to Disclose
 
Courtney Denton Dinardo
Honoraria - Agios; Daiichi Sankyo; Novartis
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo; Novartis
 
Zeev Estrov
No Relationships to Disclose
 
Tapan M. Kadia
No Relationships to Disclose
 
Naveen Pemmaraju
No Relationships to Disclose
 
Farhad Ravandi
No Relationships to Disclose
 
Carlos E. Bueso-Ramos
No Relationships to Disclose
 
Hagop M. Kantarjian
No Relationships to Disclose
 
Keyur Patel
No Relationships to Disclose
 
Guillermo Garcia-Manero
No Relationships to Disclose